Treatment of lactic acidosis: Appropriate confusion

Journal of Hospital Medicine

Volumn 5, Issue 4, 2010, Pages

  Rachoin, Jean Sebastien ^a   Weisberg, Lawrence S ^a   McFadden, Christopher B ^a  

^a RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

Lactic acidosis; Sodium bicarbonate; Treatment

Indexed keywords

BICARBONATE; BIGUANIDE DERIVATIVE; BUFFER; CARBICARB; DICHLOROACETIC ACID; LACTIC ACID; LINEZOLID; LORAZEPAM; METFORMIN; PHENFORMIN; RNA DIRECTED DNA POLYMERASE INHIBITOR; TROMETAMOL;

CORI CYCLE; HUMAN; ISCHEMIA; LACTIC ACIDOSIS; METABOLISM; MORBIDITY; MORTALITY; PATHOGENESIS; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; REVIEW;

ACIDOSIS, LACTIC; HOSPITALIZATION; HUMANS; SODIUM BICARBONATE; UNITED STATES;

EID: 77950937978     PISSN: 15535592     EISSN: 15535606     Source Type: Journal    
DOI: 10.1002/jhm.600     Document Type: Review

References (127)

1. Cooper DJ, Walley KR, Wiggs BR, Russell JA. Bicarbonate does not improve hemodynamics in critically ill patients who have lactic acidosis. A prospective, controlled clinical study. Ann Intern Med. 1990;112(7):492-498.
2. Stacpoole PW, Wright EC, Baumgartner TG, et al. Natural history and course of acquired lactic acidosis in adults. DCA-Lactic Acidosis Study Group. Am J Med. 1994;97(1):47-54.
3. Forsythe SM, Schmidt GA. Sodium bicarbonate for the treatment of lactic acidosis. Chest. 2000;117(1):260-267.
4. Adrogue HJ, Madias NE. Management of life-threatening acid-base disorders. First of two parts. N Engl J Med. 1998;338(1):26-34. (Pubitemid 28040173)
5. Arieff AI. Indications for use of bicarbonate in patients with metabolic acidosis. Br J Anaesth. 1991;67(2):165-177.
6. Gehlbach BK, Schmidt GA. Bench-to-bedside review: treating acid-base abnormalities in the intensive care unit - the role of buffers. Crit Care. 2004;8(4):259-265. (Pubitemid 39144716)
7. Luft FC. Lactic acidosis update for critical care clinicians. J Am Soc Nephrol. 2001;12(suppl 17):S15-S19.
8. Cohen RD, Iles RA. Lactic acidosis: diagnosis and treatment. Clin Endocrinol Metab. 1980;9(3):513-541.
9. Levy B. Lactate and shock state: the metabolic view. Curr Opin Crit Care. 2006;12(4):315-321. (Pubitemid 44078143)
10. Bellomo R. Bench-to-bedside review: lactate and the kidney. Crit Care. 2002;6(4):322-326.
11. Bartlett S, Espinal J, Janssens P, Ross BD. The influence of renal function on lactate and glucose metabolism. Biochem J. 1984;219(1):73-78. (Pubitemid 14171450)
12. Yudkin J, Cohen RD. The effect of acidosis on lactate removal by the perfused rat kidney. Clin Sci Mol Med. 1976;50(3):185-194.
13. Bellomo R, Kellum JA, Pinsky MR. Transvisceral lactate fluxes during early endotoxemia. Chest. 1996;110(1):198-204. (Pubitemid 26249324)
14. Leal-Pinto E, Park HC, King F, MacLeod M, Pitts RF. Metabolism of lactate by the intact functioning kidney of the dog. Am J Physiol. 1973;224(6):1463- 1467.
15. Revelly JP, Tappy L, Martinez A, et al. Lactate and glucose metabolism in severe sepsis and cardiogenic shock. Crit Care Med. 2005;33(10):2235-2240. (Pubitemid 41437476)
16. Bihari D, Gimson AE, Lindridge J, Williams R, et al. Lactic acidosis in fulminant hepatic failure. Some aspects of pathogenesis and prognosis. J Hepatol. 1985;1(4):405-416. (Pubitemid 15044211)
17. Mizock BA, Falk JL. Lactic acidosis in critical illness. Crit Care Med. 1992;20(1):80-93.
18. Chiolero RL, Revelly JP, Leverve X, et al. Effects of cardiogenic shock on lactate and glucose metabolism after heart surgery. Crit Care Med. 2000;28(12):3784-3791. (Pubitemid 32044473)
19. Levy B, Sadoune LO, Gelot AM, Bollaert PE, Nabet P, Larcan A. Evolution of lactate/pyruvate and arterial ketone body ratios in the early course of catecholamine-treated septic shock. Crit Care Med. 2000;28(1):114-119. (Pubitemid 30091039)
20. Dunham CM, Siegel JH, Weireter L, et al. Oxygen debt and metabolic acidemia as quantitative predictors of mortality and the severity of the ischemic insult in hemorrhagic shock. Crit Care Med. 1991;19(2):231-243.
21. Rivers E, Nguyen B, Havstad S, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med. 2001;345(19):1368- 1377.
22. Boekstegers P, Weidenhöfer S, Kapsner T, Werdan K. Skeletal muscle partial pressure of oxygen in patients with sepsis. Crit Care Med. 1994;22(4):640-650. (Pubitemid 24121566)
23. Hotchkiss RS, Karl IE. Reevaluation of the role of cellular hypoxia and bioenergetic failure in sepsis. JAMA. 1992;267(11):1503-1510.
24. Gore DC, Jahoor F, Hibbert JM, DeMaria EJ. Lactic acidosis during sepsis is related to increased pyruvate production, not deficits in tissue oxygen availability. Ann Surg. 1996;224(1):97-102. (Pubitemid 26230130)
25. Gan SC, Barr J, Arieff AI, Pearl RG. Biguanide-associated lactic acidosis. Case report and review of the literature. Arch Intern Med. 1992;152(11):2333-2336.
26. Claessens YE, Chiche JD, Mira JP, Cariou A. Bench-to-bedside review: severe lactic acidosis in HIV patients treated with nucleoside analogue reverse transcriptase inhibitors. Crit Care. 2003;7(3):226-232. (Pubitemid 36748883)
27. Wiener M, Guo Y, Patel G, Fries BC. Lactic acidosis after treatment with linezolid. Infection. 2007;35(4):278-281.
28. Wolfe RR, Jahoor F, Herndon DN, Miyoshi H. Isotopic evaluation of the metabolism of pyruvate and related substrates in normal adult volunteers and severely burned children: effect of dichloroacetate and glucose infusion. Surgery. 1991;110(1):54-67.
29. Mizock BA. Alterations in carbohydrate metabolism during stress: a review of the literature. Am J Med. 1995;98(1):75-84.
30. Druml W. Grimm G, Laggner AN, Lenz K, Schneeweiss B. Lactic acid kinetics in respiratory alkalosis. Crit Care Med. 1991;19(9):1120-1124.
31. Mizock BA. Significance of hyperlactatemia without acidosis during hypermetabolic stress. Crit Care Med. 1997;25(11):1780-1781.
32. James JH, Luchette FA, McCarter FD, Fischer JE. Lactate is an unreliable indicator of tissue hypoxia in injury or sepsis. Lancet. 1999;354(9177):505-508.
33. Levy B, Gibot S, Franck P, Cravoisy A, Bollaert PE. Relation between muscle Na+K+ ATPase activity and raised lactate concentrations in septic shock: a prospective study. Lancet. 2005;365(9462):871-875. (Pubitemid 40332165)
34. Callahan LA, Supinski GS. Sepsis induces diaphragm electron transport chain dysfunction and protein depletion. Am J Respir Crit Care Med. 2005;172(7):861-868. (Pubitemid 41369070)
35. Brealey D, Brand M, Hargreaves I, et al. Association between mitochondrial dysfunction and severity and outcome of septic shock. Lancet. 2002;360(9328):219-223. (Pubitemid 34804650)
36. Singer M, Brealey D. Mitochondrial dysfunction in sepsis. Biochem Soc Symp. 1999;66:149-166.
37. Zeller WP, The SM, Sweet M, et al. Altered glucose transporter mRNA abundance in a rat model of endotoxic shock. Biochem Biophys Res Commun. 1991;176(1):535-540.
38. Vary TC. Increased pyruvate dehydrogenase kinase activity in response to sepsis. Am J Physiol. 1991;260(5 Pt 1):E669-E674.
39. Gladden LB. Lactate metabolism: a new paradigm for the third millennium. J Physiol. 2004;558(Pt 1):5-30.
40. Pellerin L, Pellegri G, Bittar PG, et al. Evidence supporting the existence of an activity-dependent astrocyte-neuron lactate shuttle. Dev Neurosci. 1998;20(4-5):291-299. (Pubitemid 28495523)
41. Schurr A, Payne RS, Miller JJ, Rigor BM. Brain lactate is an obligatory aerobic energy substrate for functional recovery after hypoxia: further in vitro validation. J Neurochem. 1997;69(1):423-426. (Pubitemid 27274200)
42. Schurr A. Bench-to-bedside review: a possible resolution of the glucose paradox of cerebral ischemia. Crit Care. 2002;6(4):330-334. (Pubitemid 34863701)
43. King P, Kong MF, Parkin H, MacDonald IA, Barber C, Tattersall RB. Intravenous lactate prevents cerebral dysfunction during hypoglycaemia in insulin-dependent diabetes mellitus. Clin Sci (Lond). 1998;94(2):157-163. (Pubitemid 28052646)
44. Schurr A, Payne RS, Miller JJ, Rigor BM. Brain lactate, not glucose, fuels the recovery of synaptic function from hypoxia upon reoxygenation: an in vitro study. Brain Res. 1997;744(1):105-111. (Pubitemid 27033584)
45. Gogos CA, Lekkou A, Papageorgiou O, Siagris D, Skoutelis A, Bassaris HP. Clinical prognostic markers in patients with severe sepsis: a prospective analysis of 139 consecutive cases. J Infect. 2003;47(4):300-306. (Pubitemid 37322049)
46. Trzeciak S, Dellinger RP, Chansky ME, et al. Serum lactate as a predictor of mortality in patients with infection. Intensive Care Med. 2007;33(6):970-977. (Pubitemid 46835396)
47. Gunnerson KJ, Saul M, He S, Kellum JA. Lactate versus non-lactate metabolic acidosis: a retrospective outcome evaluation of critically ill patients. Crit Care. 2006;10(1):R22. (Pubitemid 47079799)
48. Huckabee WE. Abnormal resting blood lactate. I. The significance of hyperlactatemia in hospitalized patients. Am J Med. 1961;30:840-848.
49. Teplinsky K, O'Toole M, Olman M, Walley KR, Wood LD. Effect of lactic acidosis on canine hemodynamics and left ventricular function. Am J Physiol. 1990;258(4 Pt 2):H1193-H1199. (Pubitemid 20155567)
50. Halperin FA, Cheema-Dhadli S, Chen CB, Halperin ML. Alkali therapy extends the period of survival during hypoxia: studies in rats. Am J Physiol. 1996;271(2 Pt 2):R381-R387. (Pubitemid 26295177)
51. Kitakaze M, Weisfeldt ML, Marban E. Acidosis during early reperfusion prevents myocardial stunning in perfused ferret hearts. J Clin Invest. 1988;82(3):920-927.
52. Preckel B, Schlack W, Obal D, et al. Effect of acidotic blood reperfusion on reperfusion injury after coronary artery occlusion in the dog heart. J Cardiovasc Pharmacol. 1998;31(2):179-186. (Pubitemid 28099157)
53. Kubasiak LA, Hernandez OM, Bishopric NH, Webster KA. Hypoxia and acidosis activate cardiac myocyte death through the Bcl-2 family protein BNIP3. Proc Natl Acad Sci U S A. 2002;99(20):12825-12830.
54. Gores GJ, Nieminen AL, Fleishman KE, Dawson TL, Herman B, Lemasters JJ. Extracellular acidosis delays onset of cell death in ATP-depleted hepatocytes. Am J Physiol. 1988;255(3 Pt 1):C315-C322.
55. Mustafa I, Leverve XM. Metabolic and hemodynamic effects of hypertonic solutions: sodium-lactate versus sodium chloride infusion in postoperative patients. Shock. 2002;18(4):306-310.
56. Glaser GH. Medical complications of status epilepticus. Adv Neurol. 1983;34:395-398.
57. Gamba G, Nieminen AL, Fleishman KE, Dawson TL, Herman B, Lemasters JJ. Bicarbonate therapy in severe diabetic ketoacidosis. A double blind, randomized, placebo controlled trial. Rev Invest Clin. 1991;43(3):234-238.
58. Goldstein B, Shannon DC, Todres ID. Supercarbia in children: clinical course and outcome. Crit Care Med. 1990;18(2):166-168. (Pubitemid 20053009)
59. Hickling KG, Walsh J, Henderson S, Jackson R. Low mortality rate in adult respiratory distress syndrome using low-volume, pressure-limited ventilation with permissive hypercapnia: a prospective study. Crit Care Med. 1994;22(10):1568-1578. (Pubitemid 24320879)
60. 3 in experimental lactic acidosis in dogs. Am J Physiol. 1982;242(6):F586-F591.
61. Zahler R, Barrett E, Majumdar S, Greene R, Gore JC. Lactic acidosis: effect of treatment on intracellular pH and energetics in living rat heart. Am J Physiol. 1992;262(5 Pt 2):H1572-H1578.
62. Levraut J, Labib Y, Chave S, Payan P, Raucoules-Aime M, Grimaud D. Effect of sodium bicarbonate on intracellular pH under different buffering conditions. Kidney Int. 1996;49(5):1262-1267. (Pubitemid 26166402)
63. Shapiro JI, Whalen M, Chan L. Hemodynamic and hepatic pH responses to sodium bicarbonate and Carbicarb during systemic acidosis. Magn Reson Med. 1990;16(3):403-410.
64. 3 depends on blood albumin and hemoglobin concentrations. Intensive Care Med. 2000;26(5):558-564.
65. Levraut J, Giunti C, Ciebiera JP, et al. Initial effect of sodium bicarbonate on intracellular pH depends on the extracellular nonbicarbonate buffering capacity. Crit Care Med. 2001;29(5):1033-1039. (Pubitemid 32424359)
66. Hiltebrand LB, Krejci V, Banic A, Erni D, Wheatley AM, Sigurdsson GH. Dynamic study of the distribution of microcirculatory blood flow in multiple splanchnic organs in septic shock. Crit Care Med. 2000;28(9):3233-3241.
67. Beech JS, Nolan KM, Iles RA, Cohen RD, Williams SC, Evans SJ. The effects of sodium bicarbonate and a mixture of sodium bicarbonate and carbonate ("Carbicarb") on skeletal muscle pH and hemodynamic status in rats with hypovolemic shock. Metabolism. 1994;43(4):518-522.
68. Beech JS, Williams SC, Iles RA, et al. Haemodynamic and metabolic effects in diabetic ketoacidosis in rats of treatment with sodium bicarbonate or a mixture of sodium bicarbonate and sodium carbonate. Diabetologia. 1995;38(8):889-898.
69. Bollaert PE, Robin-Lherbier B, Mallie JP, Nace L, Escanye JM, Larcan A. Effects of sodium bicarbonate on striated muscle metabolism and intracellular pH during endotoxic shock. Shock. 1994;1(3):196-200.
70. Rhee KH, Toro LO, McDonald GG, Nunnally RL, Levin DL. Carbicarb, sodium bicarbonate, and sodium chloride in hypoxic lactic acidosis. Effect on arterial blood gases, lactate concentrations, hemodynamic variables, and myocardial intracellular pH. Chest. 1993;104(3):913-918.
71. Bersin RM, Arieff AI. Improved hemodynamic function during hypoxia with Carbicarb, a new agent for the management of acidosis. Circulation. 1988;77(1):227-233.
72. Graf H, Leach W, Arieff AI. Metabolic effects of sodium bicarbonate in hypoxic lactic acidosis in dogs. Am J Physiol. 1985;249(5 Pt 2):F630-F635. (Pubitemid 16196083)
73. Pedersen KO. Binding of calcium to serum albumin. II. Effect of pH via competitive hydrogen and calcium ion binding to the imidazole groups of albumin. Scand J Clin Lab Invest. 1972;29(1):75-83.
74. Lang RM, Fellner SK, Neumann A, Bushinsky DA, Borow KM. Left ventricular contractility varies directly with blood ionized calcium. Ann Intern Med. 1988;108(4):524-529.
75. Bellingham AJ, Detter JC, Lenfant C. Regulatory mechanisms of hemoglobin oxygen affinity in acidosis and alkalosis. J Clin Invest. 1971;50(3):700-706.
76. Bersin RM, Chatterjee K, Arieff AI. Metabolic and hemodynamic consequences of sodium bicarbonate administration in patients with heart disease. Am J Med. 1989;87(1):7-14. (Pubitemid 19179403)
77. Levitsky J, Gurell D, Frishman WH. Sodium ion/hydrogen ion exchange inhibition: a new pharmacologic approach to myocardial ischemia and reperfusion injury. J Clin Pharmacol. 1998;38(10):887-897. (Pubitemid 28482113)
78. Lee C, Hryshko LV. SEA0400: a novel sodium-calcium exchange inhibitor with cardioprotective properties. Cardiovasc Drug Rev. 2004;22(4):334-347. (Pubitemid 40116806)
79. Steenbergen C, Murphy E, Levy L, London RE. Elevation in cytosolic free calcium concentration early in myocardial ischemia in perfused rat heart. Circ Res. 1987;60(5):700-707. (Pubitemid 17098135)
80. Tanaka M, Nishikawa T. Acute haemodynamic effects of sodium bicarbonate administration in respiratory and metabolic acidosis in anaesthetized dogs. Anaesth Intensive Care. 1997;25(6):615-620. (Pubitemid 28021451)
81. Cooper DJ, Herbertson MJ, Werner HA, Walley KR. Bicarbonate does not increase left ventricular contractility during L-lactic acidemia in pigs. Am Rev Respir Dis. 1993;148(2):317-322.
82. Mathieu D, Neviere R, Billard V, Fleyfel M, Wattel F. Effects of bicarbonate therapy on hemodynamics and tissue oxygenation in patients with lactic acidosis: a prospective, controlled clinical study. Crit Care Med. 1991;19(11):1352-1356.
83. Leung JM, Landow L, Franks M, et al. Safety and efficacy of intravenous Carbicarb in patients undergoing surgery: comparison with sodium bicarbonate in the treatment of mild metabolic acidosis. SPI Research Group. Study of Perioperative Ischemia. Crit Care Med. 1994;22(10):1540-1549.
84. Hoste EA, Colpaert K, Vanholder RC, et al. Sodium bicarbonate versus THAM in ICU patients with mild metabolic acidosis. J Nephrol. 2005;18(3):303-307. (Pubitemid 41078950)
85. Stacpoole PW, Wright EC, Baumgartner TG, et al. A controlled clinical trial of dichloroacetate for treatment of lactic acidosis in adults. The Dichloroacetate-Lactic Acidosis Study Group. N Engl J Med. 1992;327(22):1564- 1569.
86. Levraut J, Ciebiera JP, Jambou P, Ichai C, Labib Y, Grimaud D. Effect of continuous venovenous hemofiltration with dialysis on lactate clearance in critically ill patients. Crit Care Med. 1997;25(1):58-62. (Pubitemid 27015040)
87. Baldwin I, Naka T, Koch B, Fealy N, Bellomo R. A pilot randomised controlled comparison of continuous veno-venous haemofiltration and extended daily dialysis with filtration: effect on small solutes and acid-base balance. Intensive Care Med. 2007;33(5):830-835. (Pubitemid 46675330)
88. Uchino S, Bellomo R, Ronco C. Intermittent versus continuous renal replacement therapy in the ICU: impact on electrolyte and acid-base balance. Intensive Care Med. 2001;27(6):1037-1043. (Pubitemid 32662486)
89. Salpeter SR, Greyber E, Pasternak GA, Salpeter EE. Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus: systematic review and meta-analysis. Arch Intern Med. 2003;163(21):2594-2602. (Pubitemid 37464417)
90. Nyirenda MJ, Sandeep T, Grant I, Price G, McKnight JA. Severe acidosis in patients taking metformin - rapid reversal and survival despite high APACHE score. Diabet Med. 2006;23(4):432-435.
91. Stang M, Wysowski DK, Butler-Jones D. Incidence of lactic acidosis in metformin users. Diabetes Care. 1999;22(6):925-927. (Pubitemid 29241046)
92. Lalau JD, Race JM. Lactic acidosis in metformin-treated patients. Prognostic value of arterial lactate levels and plasma metformin concentrations. Drug Saf. 1999;20(4):377-384.
93. Teale KF, Devine A, Stewart H, Harper NJ. The management of metformin overdose. Anaesthesia. 1998;53(7):698-701.
94. Luft D, Schmulling RM, Eggstein M. Lactic acidosis in biguanide-treated diabetics: a review of 330 cases. Diabetologia. 1978;14(2):75-87. (Pubitemid 8277514)
95. Chalopin JM, Tanter Y, Besancenot JF, Cabanne JF, Rifle G. Treatment of metformin-associated lactic acidosis with closed recirculation bicarbonate-buffered hemodialysis. Arch Intern Med. 1984;144(1):203-205. (Pubitemid 14217992)
96. Chang CT, Chen YC, Fang JT, Huang CC. High anion gap metabolic acidosis in suicide: don't forget metformin intoxication - two patients' experiences. Ren Fail. 2002;24(5):671-675.
97. Lalau JD, Andrejak M, Morinière P, et al. Hemodialysis in the treatment of lactic acidosis in diabetics treated by metformin: a study of metformin elimination. Int J Clin Pharmacol Ther Toxicol. 1989;27(6):285-288. (Pubitemid 19147149)
98. Heaney D, Majid A, Junor B. Bicarbonate haemodialysis as a treatment of metformin overdose. Nephrol Dial Transplant. 1997;12(5):1046-1047. (Pubitemid 27216337)
99. Panzer U, Kluge S, Kreymann G, Wolf G. Combination of intermittent haemodialysis and high-volume continuous haemofiltration for the treatment of severe metformin-induced lactic acidosis. Nephrol Dial Transplant. 2004;19(8):2157-2158. (Pubitemid 39139660)
100. Prikis M, Mesler EL, Hood VL, Weise WJ. When a friend can become an enemy! Recognition and management of metformin-associated lactic acidosis. Kidney Int. 2007;72(9):1157-1160. (Pubitemid 47609030)
101. Falco V. Rodríguez D, Ribera E, et al. Severe nucleoside- associated lactic acidosis in human immunodeficiency virus-infected patients: report of 12 cases and review of the literature. Clin Infect Dis. 2002;34(6):838-846. (Pubitemid 34194856)
102. Barrueto F, Meggs WJ, Barchman MJ. Clearance of metformin by hemofiltration in overdose. J Toxicol Clin Toxicol. 2002;40(2):177-180.
103. Kruse JA. Metformin-associated lactic acidosis. J Emerg Med. 2001;20(3):267-272.
104. Jones P, Yate P. Contraindications to use of metformin. Blanket banning of metformin two days before surgery may not be a good idea. BMJ. 2003;326(7392):762; author reply 762.
105. McKenzie R, Fried MW, Sallie R, et al. Hepatic failure and lactic acidosis due to fialuridine (FIAU), an investigational nucleoside analogue for chronic hepatitis B. N Engl J Med. 1995;333(17):1099-1105.
106. Sundar K, Suarez M, Banogon PE, Shapiro JM. Zidovudine-induced fatal lactic acidosis and hepatic failure in patients with acquired immunodeficiency syndrome: report of two patients and review of the literature. Crit Care Med. 1997;25(8):1425-1430. (Pubitemid 27347311)
107. Lewis W, Dalakas MC. Mitochondrial toxicity of antiviral drugs. Nat Med. 1995;1(5):417-422.
108. Brinkman K, Kakuda TN. Mitochondrial toxicity of nucleoside analogue reverse transcriptase inhibitors: a looming obstacle for long-term antiretroviral therapy? Curr Opin Infect Dis. 2000;13(1):5-11.
109. Hammer SM, Saag MS, Schechter M, et al. Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society-USA panel. JAMA. 2006;296(7):827-843.
110. Fouty B, Frerman F, Reves R. Riboflavin to treat nucleoside analogue-induced lactic acidosis. Lancet. 1998;352(9124):291-292. (Pubitemid 28340157)
111. Arici C, Tebaldi A, Quinzan GP, Maggiolo F, Ripamonti D, Suter F. Severe lactic acidosis and thiamine administration in an HIV-infected patient on HAART. Int J STD AIDS. 2001;12(6):407-409. (Pubitemid 32538882)
112. Claessens YE, Cariou A, Monchi M, et al. Detecting life-threatening lactic acidosis related to nucleoside-analog treatment of human immunodeficiency virus-infected patients, and treatment with L-carnitine. Crit Care Med. 2003;31(4):1042-1047. (Pubitemid 36444411)
113. Mullins ME, Barnes BJ. Hyperosmolar metabolic acidosis and intravenous Lorazepam. N Engl J Med. 2002;347(11):857-858; author reply 857-858.
114. Wilson KC, Reardon C, Theodore AC, Farber HW. Propylene glycol toxicity: a severe iatrogenic illness in ICU patients receiving IV benzodiazepines: a case series and prospective, observational pilot study. Chest. 2005;128(3):1674- 1681. (Pubitemid 41324463)
115. Speth PA, Vree TB, Neilen NF, et al. Propylene glycol pharmacokinetics and effects after intravenous infusion in humans. Ther Drug Monit. 1987;9(3):255-258.
116. Cawley MJ. Short-term lorazepam infusion and concern for propylene glycol toxicity: case report and review. Pharmacotherapy. 2001;21(9):1140-1144.
117. Zar T, Graeber C, Perazella MA. Recognition, treatment, and prevention of propylene glycol toxicity. Semin Dial. 2007;20(3):217-219.
118. Morshed KM, Jain SK, McMartin KE. Propylene glycol-mediated cell injury in a primary culture of human proximal tubule cells. Toxicol Sci. 1998;46(2):410-417.
119. Arbour R, Esparis B. Osmolar gap metabolic acidosis in a 60-year-old man treated for hypoxemic respiratory failure. Chest. 2000;118(2):545-546. (Pubitemid 30637829)
120. Arroliga AC, Shehab N, McCarthy K, Gonzales JP. Relationship of continuous infusion lorazepam to serum propylene glycol concentration in critically ill adults. Crit Care Med. 2004;32(8):1709-1714. (Pubitemid 39050522)
121. Parker MG, Fraser GL, Watson DM, Riker RR. Removal of propylene glycol and correction of increased osmolar gap by hemodialysis in a patient on high dose lorazepam infusion therapy. Intensive Care Med. 2002;28(1):81-84.
122. Kopterides P, Papadomichelakis E, Armaganidis A. Linezolid use associated with lactic acidosis. Scand J Infect Dis. 2005;37(2):153-154. (Pubitemid 40298173)
123. Apodaca AA, Rakita RM. Linezolid-induced lactic acidosis. N Engl J Med. 2003;348(1):86-87.
124. Beekmann SE, Gilbert DN, Polgreen PM. Toxicity of extended courses of linezolid: results of an Infectious Diseases Society of America Emerging Infections Network survey. Diagn Microbiol Infect Dis. 2008;62(4):407-410.
125. Soriano A, Miro O, Mensa J. Mitochondrial toxicity associated with linezolid. N Engl J Med. 2005;353(21):2305-2306.
126. De Vriese AS, Coster RV, Smet J, et al. Linezolid-induced inhibition of mitochondrial protein synthesis. Clin Infect Dis. 2006;42(8):1111-1117.
127. Kraut JA, Kurtz I. Use of base in the treatment of severe acidemic states. Am J Kidney Dis. 2001;38(4):703-727. (Pubitemid 32927895)